News – Page 530 – Endpoints News

DCT startup looking to forge better community relationships nets a modest Series B

4 years ago

Enhertu wins another breast cancer approval, as AstraZeneca and Daiichi Sankyo prepare to corner the market

4 years ago

Jazz doubles down on sleep disorders, putting down $50M cash to pluck Sumitomo drug for the pipeline

4 years ago

A virus may have driven the death of the first patient to receive a genetically modified pig heart

4 years ago

AstraZeneca adds a major PhIII win for Farxiga, setting up another battlefront with Big Pharma rivals

4 years ago

Despite Albert Bourla's comments, FDA tells doctors not to re-treat with Paxlovid if symptoms rebound

4 years ago

Idorsia rolls out insomnia med Quviviq with sales team, digital marketing and DTC in the works

4 years ago

In wake of massive year-over-year growth, Moderna reserves its buyers seat at the global deals table

4 years ago

Amazon subsidiary PillPack reaches a settlement with US government and will have to shell out over $5.6M

4 years ago

Novartis' compassionate use requests worldwide: Just 0.5% came from lower-middle- and low-income countries

4 years ago

Novotech extends arms into US with acquisition of a South Carolina CRO

4 years ago

Incyte changes manufacturing process, adds second site to solve Opzelura texture issue

4 years ago

Former FDA chief of staff steps into VP role at Philip Morris as CDMO pivot continues

4 years ago

AstraZeneca poised to snag fast approval for a frontline use of Imfinzi, adding to its growing oncology portfolio

4 years ago

AbbVie pulls back the curtain on its leaders across disciplines in conversational Q&A series ‘Magnified’

4 years ago

BerGenBio narrows R&D to focus on NSCLC and Covid-19; Oral SERDs see another setback as G1 drops program

4 years ago

FDA releases second Pfizer gene therapy from clinical hold, as hemophilia program gets OK to restart

4 years ago

Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study

4 years ago

An upstart protein degradation contender adds Merck KGaA and Bristol Myers to its list of Big Pharma backers

4 years ago

Takeda GI spinout nabs approval for only drug — and pivots to a quick raise

4 years ago

Feeling the pain of a bear market, MacroGenics plans to start a PhII/III by year's end — once they raise the cash

4 years ago

Days after flagging its $773M takeover bid, Zymeworks minority shareholder adds AstraZeneca oncology vet to the crew

4 years ago

Sleep apnea biotech breathes easy with $62.5M financing ahead of PhIII trials for lead oral drug

4 years ago

Biogen CEO Vounatsos, board and top execs formally agreed to keep the breakup civil

4 years ago

First page Previous page 527 528 529530531 532 533 Next page Last page